ABBV (STOCKS)
ABBVIE INC.
$206.890000
-1.050000 (-0.50%)
Prev close: $207.940000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert A. Michael
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $365,134.46M
- Employees
- 55,000
- P/E (TTM)
- 88.07
- P/B (TTM)
- -112.42
- Dividend Yield
- 319.80%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $61.16B |
| Benefits Costs and Expenses | $54.56B |
| Cost Of Revenue | $18.20B |
| Costs And Expenses | $46.09B |
| Gross Profit | $42.96B |
| Operating Expenses | $27.88B |
| Selling, General, and Administrative Expenses | $14.01B |
| Other Operating Expenses | $13.87B |
| Operating Income/Loss | $15.08B |
| Income/Loss From Continuing Operations After Tax | $4.23B |
| Income/Loss From Continuing Operations Before Tax | $6.60B |
| Income Tax Expense/Benefit | $2.36B |
| Income Tax Expense/Benefit, Current | $2.86B |
| Income Tax Expense/Benefit, Deferred | -$492.00M |
| Interest Expense, Operating | $2.89B |
| Net Income/Loss | $4.23B |
| Net Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Net Income/Loss Attributable To Parent | $4.23B |
| Net Income/Loss Available To Common Stockholders, Basic | $4.19B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $40.00M |
| Preferred Stock Dividends And Other Adjustments | $40.00M |
| Basic Earnings Per Share | $2.37 |
| Diluted Earnings Per Share | $2.36 |
| Basic Average Shares | 1,769,000,000 |
| Diluted Average Shares | 1,773,000,000 |
| Assets | $133.96B |
| Current Assets | $29.06B |
| Inventory | $4.95B |
| Other Current Assets | $24.11B |
| Noncurrent Assets | $104.90B |
| Fixed Assets | $5.63B |
| Intangible Assets | $52.64B |
| Other Non-current Assets | $46.63B |
| Liabilities | $137.19B |
| Current Liabilities | $43.29B |
| Accounts Payable | $3.59B |
| Wages | $2.22B |
| Other Current Liabilities | $37.48B |
| Noncurrent Liabilities | $93.90B |
| Long-term Debt | $64.50B |
| Other Non-current Liabilities | $29.40B |
| Equity | -$3.23B |
| Equity Attributable To Noncontrolling Interest | $42.00M |
| Equity Attributable To Parent | -$3.27B |
| Liabilities And Equity | $133.96B |
| Net Cash Flow From Operating Activities | $19.03B |
| Net Cash Flow From Operating Activities, Continuing | $19.03B |
| Net Cash Flow From Investing Activities | -$6.64B |
| Net Cash Flow From Investing Activities, Continuing | -$6.64B |
| Net Cash Flow From Financing Activities | -$12.72B |
| Net Cash Flow From Financing Activities, Continuing | -$12.72B |
| Exchange Gains/Losses | $42.00M |
| Net Cash Flow | -$295.00M |
| Net Cash Flow, Continuing | -$337.00M |
| Comprehensive Income/Loss | $5.01B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Comprehensive Income/Loss Attributable To Parent | $5.01B |
| Other Comprehensive Income/Loss | $781.00M |